Clinical Trial Update: VX-770 for the Treatment of Chronic Bronchitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating VX-770 for chronic bronchitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• VX-770 (ivacaftor)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Chronic Bronchitis | Phase 4 | Status: WITHDRAWN